HEALTH TECH
AI startups are racing into drug development. Here's 5 burning questions about which will survive
By Rebecca Robbins
By Rebecca Robbins
About two years ago, Simon Smith started counting the startups trying to bring artificial intelligence to drug development. Smith, an AI startup executive himself, found about 30 of them. Now? His tally is up to 148. And VCs are watching closely for signs of which companies will succeed in an increasingly crowded market.
.png)
No hay comentarios:
Publicar un comentario